This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shanghai Raas Blood Products Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Xuefeng Zhou: Innovator in Genetic Engineering
Introduction
Xuefeng Zhou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of genetic engineering, particularly in the development of genetically modified organisms. His work focuses on enhancing the understanding of human proteins and their therapeutic applications.
Latest Patents
Xuefeng Zhou holds a patent for a "Humanized knock-in mouse expressing human Protein C." This invention involves a genetically modified non-human animal, where at least one copy of the endogenous nucleotide sequence encoding Protein C has been replaced by a nucleotide sequence encoding human Protein C or a functional fragment or variant thereof. The patent also includes vectors, cells, and methods for producing such non-human animals. Additionally, it provides methods for testing agents that can alter the level and/or functional activity of human Protein C, which may have potential therapeutic efficacy.
Career Highlights
Xuefeng Zhou is associated with Shanghai Raas Blood Products Co., Ltd., where he applies his expertise in genetic modifications. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements in medical research and therapeutic solutions.
Collaborations
Xuefeng Zhou collaborates with notable colleagues, including Jun Xu and Lu Cheng. Their combined efforts in research and development have furthered the understanding of genetic engineering and its applications in medicine.
Conclusion
Xuefeng Zhou's contributions to genetic engineering, particularly through his patented innovations, highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile